A Single-Dose Pharmacokinetics Study of Tapimycin Injection
NCT00924742
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Tapimycin (piperacillin 4 g + tazobactam 0.5g)
Sponsor
Tri-Service General Hospital